🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study was a randomized, double-blind, placebo-controlled, mult...
Status
Completed
Location
The Second Hospital of Anhui Medical University
Start Date
2019-07-22
Trial ID
NCT04005716
Treatments Being Tested
The objective of this study is to assess the overall response rate, evaluat...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-01-09
Trial ID
NCT05661955
Treatments Being Tested
The primary scientific question of interest of this study is whether the co...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-09-15
Trial ID
NCT05809895
Treatments Being Tested
The purpose of this study is to test the safety and tolerability of HFB2003...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2022-03-10
Trial ID
NCT05238883
Treatments Being Tested
This is a Phase 2, multi-cohort study to investigate safety, anti-tumor act...
Status
Completed
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2021-03-06
Trial ID
NCT04963088
Treatments Being Tested
This was an open-label, multicenter, nonrandomized Phase 1 and 2 clinical t...
Status
Completed
Location
Chao Family Comprehensive Cancer Center
Start Date
2018-11-13
Trial ID
NCT03744468
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of tisleliz...
Status
Terminated
Location
Beijing Cancer Hospital
Start Date
2020-12-14
Trial ID
NCT04486391
Treatments Being Tested
A prospective, randomized, open-label, multicenter Phase 3 trial designed t...
Status
Recruiting
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2022-10-28
Trial ID
NCT05582265
This study will evaluate the safety, tolerability, pharmacokinetics (PK), a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-03
Trial ID
NCT05644626
Treatments Being Tested
This study was designed to compare the efficacy and safety of tislelizumab ...
Status
Completed
Location
University of California Davis Health System
Start Date
2018-12-13
Trial ID
NCT03777657
Treatments Being Tested